Literature DB >> 12081906

Vascular assembly in natural and engineered tissues.

Karen K Hirschi1, Thomas C Skalak, Shayn M Peirce, Charles D Little.   

Abstract

With the advent of molecular embryology and exploitation of genetic models systems, many genes necessary for normal blood vessel formation during early development have been identified. These genes include soluble effectors and their receptors, as well as components of cell-cell junctions and mediators of cell-matrix interactions. In vitro model systems (2-D and 3-D) to study paracrine and autocrine interactions of vascular cells and their progenitors have also been created. These systems are being combined to study the behavior of genetically altered cells to dissect and define the cellular role(s) of specific genes and gene families in directing the migration, proliferation, and differentiation needed for blood vessel assembly. It is clear that a complex spatial and temporal interplay of signals, including both genetic and environmental, modulates the assembly process. The development of real-time imaging and image analysis will enable us to gain further insights into this process. Collaborative efforts among vascular biologists, biomedical engineers, mathematicians, and physicists will allow us to bridge the gap between understanding vessel assembly in vivo and assembling vessels ex vivo.

Mesh:

Year:  2002        PMID: 12081906     DOI: 10.1111/j.1749-6632.2002.tb03090.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  21 in total

1.  Vascular morphogenesis of adipose-derived stem cells is mediated by heterotypic cell-cell interactions.

Authors:  Daphne L Hutton; Elizabeth A Logsdon; Erika M Moore; Feilim Mac Gabhann; Jeffrey M Gimble; Warren L Grayson
Journal:  Tissue Eng Part A       Date:  2012-05-09       Impact factor: 3.845

Review 2.  Nanoparticulate systems for growth factor delivery.

Authors:  Sufeng Zhang; Hasan Uludağ
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

Review 3.  Polymeric growth factor delivery strategies for tissue engineering.

Authors:  Ruth R Chen; David J Mooney
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

Review 4.  Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials.

Authors:  James J Moon; Jennifer L West
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

5.  Mechanisms of vascular endothelial growth factor-induced pathfinding by endothelial sprouts in biomaterials.

Authors:  Amir Shamloo; Hui Xu; Sarah Heilshorn
Journal:  Tissue Eng Part A       Date:  2011-10-19       Impact factor: 3.845

6.  Co-Seeding Human Endothelial Cells with Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells on Calcium Phosphate Scaffold Enhances Osteogenesis and Vascularization in Rats.

Authors:  Xian Liu; Wenchuan Chen; Chi Zhang; Wahwah Thein-Han; Kevin Hu; Mark A Reynolds; Chongyun Bao; Ping Wang; Liang Zhao; Hockin H K Xu
Journal:  Tissue Eng Part A       Date:  2017-03-10       Impact factor: 3.845

7.  Migration of co-cultured endothelial cells and osteoblasts in composite hydroxyapatite/polylactic acid scaffolds.

Authors:  Amita R Shah; Sarita R Shah; Sunho Oh; Joo L Ong; Joseph C Wenke; C Mauli Agrawal
Journal:  Ann Biomed Eng       Date:  2011-07-16       Impact factor: 3.934

8.  Effect of exogenous adipose-derived stem cells in the early stages following free fat transplantation.

Authors:  Y I Yuan; Jianhua Gao; Feng Lu
Journal:  Exp Ther Med       Date:  2015-07-01       Impact factor: 2.447

9.  Growth and phenotypic expression of human endothelial cells cultured on a glass-reinforced hydroxyapatite.

Authors:  J M Silva Marques; P S Gomes; M A Silva; A M Silvério Cabrita; J D Santos; M H Fernandes
Journal:  J Mater Sci Mater Med       Date:  2008-11-06       Impact factor: 3.896

Review 10.  Molecular mediators of angiogenesis.

Authors:  Areck A Ucuzian; Andrew A Gassman; Andrea T East; Howard P Greisler
Journal:  J Burn Care Res       Date:  2010 Jan-Feb       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.